Internet-based Support for Young People With ADHD and Autism - a Controlled Study

ADHD Clinical Trial

Official title:

Internet-based Support and Coaching for Adolescents and Young Adults With ADHD and Autism Spectrum Disorders - a Controlled Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02300597
• Other study ID #: IBSC-2
• Status: Completed
• Phase: N/A
• Start date: September 2010
• Est. completion date: June 2015

Study information

• Verified date: May 2019
• Source: Göteborg University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Young people between age 15 and 25 with ADHD and/or autism spectrum disorders are offered internet-based support and coaching during eight weeks (chat and e-mail). Data is collected before and after the intervention and six months after end of treatment using self-report questionnaires pertaining to sense of coherence, self-esteem, quality of life, depressive and anxiety symptoms and socioeconomic status. Parents complete an assessment scale for the next of kin. After treatment the young people are interviewed regarding the quality of the intervention. A comparison group matched for age, gender and neuropsychiatric diagnosis is offered treatment as usual and is assessed at the same time points as the intervention group. The individuals are not randomized due to difficulties to recruit if the individuals do not know group assignment in advance.

Description:

Young people between age 15 and 25 with ADHD and/or autism spectrum disorders are consecutively included in the project and are offered coaching and support during eight weeks over the internet (chat and e-mail) twice a week. Data is collected before and after the intervention as well as six months after end of treatment using self-report questionnaires (Sense of Coherence (SOC), Rosenberg Self Esteem Scale, Manchester Short Assessment of Quality of Life (MANSA), Montgomery Asberg Depression Rating Scale (MADRS), and Hospital Anxiety and Depression Scale (HAD)). A parent or a partner completes an assessment scale for the next of kin. When treatment is completed, the young people are interviewed using a structured interview pertaining to the quality of the intervention. A comparison group matched for age, gender and neuropsychiatric diagnosis is offered treatment as usual (TAU) and is assessed at the same time points as the intervention group. The individuals are not randomized to the intervention and comparison groups due to difficulties to recruit if the individuals do not know group assignment in advance. In all, 24 individuals will be offered the intervention and 24 individuals will receive TAU.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 45
• Est. completion date: June 2015
• Est. primary completion date: June 2015
• Accepts healthy volunteers: No
• Gender: All
• Age group: 15 Years to 30 Years

Eligibility

Inclusion Criteria:

• ADHD and/or autism spectrum disorder

• Age 15 to 30

Exclusion Criteria:

• No current antisocial behaviour, psychotic symptoms and/or alcohol/substance abuse

Related Conditions & MeSH terms

• ADHD
• Autism Spectrum Disorder
• Autism Spectrum Disorders
• Autistic Disorder
• Child Development Disorders, Pervasive

Intervention

Other:
• Internet based support and coaching
Young people between age 15 and 25 with ADHD and/or autism spectrum disorders are offered internet-based support and coaching during eight weeks (chat and e-mail). Data is collected before and after the intervention and six months after end of treatment using self-report questionnaires pertaining to sense of coherence, self-esteem, quality of life, depressive and anxiety symptoms and socioeconomic status. Parents complete an assessment scale for the next of kin. After treatment the young people are interviewed regarding the quality of the intervention.

Locations

Country	Name	City	State
Sweden	Department of Psychiatry and Neurochemistry, Institute of Neurosceince and Physiology	Gothenburg

Sponsors (3)

Lead Sponsor	Collaborator
Göteborg University	Habilitation Skaraborg, Skovde, Södra Älvsborg Hospital

Country where clinical trial is conducted

Sweden, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	QoL	Self report questionnaire; Manchester Short Assesment of Quality of Life (MANSA), Priebe et. al. 1999.	T2: immediately after intervention; T3: 6 months after intervention. Outcome Measure is going to report a change.
Secondary	Self esteem	Self report questionnaire; Rosenberg Self-Esteem Scale (Rosenberg, 1965, 1989)	T2: immediately after intervention; T3: 6 months after intervention
Secondary	Sense of coherence	Self report questionnaire; Sense of Coherence (SOC-29), Antonovsky, 1987.	T2: immediately after intervention; T3: 6 months after intervention
Secondary	Anxiety and depressive symptoms	Self report questionnaire; Hospital Anxiety and Depression Scale (HAD), Zigmond & Snaith, 1983.	T2: immediately after intervention; T3: 6 months after intervention
Secondary	Depressive symptoms	Self report questionnaire; Montgomery Asberg Depression Rating Scale (MADRS), Montgomery & Asberg, 1979.	T2: immediately after intervention; T3: 6 months after intervention